Combined Anterior and Posterior Cervical Spinal Fusion DRG Reimbursement

Trials evaluating perioperative blood management and complication reduction strategies for combined anterior-posterior cervical fusion: randomized or pragmatic studies testing protocols such as multimodal blood conservation, standardized hemostatic agents, or enhanced intraoperative monitoring in adult patients undergoing same‑day combined anterior and posterior cervical fusion for multi‑level degenerative disease, trauma, or deformity. These studies focus on intraoperative and immediate postoperative outcomes (blood loss, transfusion rates, operative time, and wound/neurologic complications) because these variables drive inpatient length of stay and index hospitalization costs, making results directly relevant to surgical teams and payers aiming to reduce complications and resource use. Such research helps define best practices for perioperative care bundles that can lower short‑term morbidity and reimbursement variability for this high‑acuity DRG.
Comparative effectiveness trials of fusion techniques and implant strategies in combined anterior-posterior cervical procedures: prospective cohort studies or randomized device-comparison trials assessing outcomes of different graft materials, fixation constructs, or staged versus single‑session combined approaches in adults with multi‑level cervical spondylotic myelopathy, post‑laminectomy kyphosis, or complex trauma. These studies measure fusion rates, functional neurologic recovery, reoperation, hardware-related complications, and 12–24 month patient‑reported outcomes, addressing the medium‑term durability and value of surgical choices that influence readmissions and downstream costs. Results inform surgeons and payers about which technical strategies provide the best balance of clinical effectiveness and long‑term economic value for patients assigned to this DRG.
Post‑discharge outcomes and care pathway studies focused on rehabilitation, readmission risk, and cost‑effectiveness: observational or interventional studies evaluating early mobilization protocols, outpatient physical therapy timing, care coordination interventions, and readmission prevention programs in older adults and medically complex patients after combined anterior‑posterior cervical fusion. These trials assess 30‑ and 90‑day readmission rates, functional independence, opioid use, and total episode‑of‑care costs, providing evidence on optimal discharge planning and postacute care settings. Findings are important to hospitals and payers for designing bundled payment models and targeted transitional care to reduce costly readmissions and improve recovery for patients within this DRG.

Trials evaluating perioperative blood management and complication reduction strategies for combined anterior-posterior cervical fusion: randomized or pragmatic studies testing protocols such as multimodal blood conservation, standardized hemostatic agents, or enhanced intraoperative monitoring in adult patients undergoing same‑day combined anterior and posterior cervical fusion for multi‑level degenerative disease, trauma, or deformity. These studies focus on intraoperative and immediate postoperative outcomes (blood loss, transfusion rates, operative time, and wound/neurologic complications) because these variables drive inpatient length of stay and index hospitalization costs, making results directly relevant to surgical teams and payers aiming to reduce complications and resource use. Such research helps define best practices for perioperative care bundles that can lower short‑term morbidity and reimbursement variability for this high‑acuity DRG.
Comparative effectiveness trials of fusion techniques and implant strategies in combined anterior-posterior cervical procedures: prospective cohort studies or randomized device-comparison trials assessing outcomes of different graft materials, fixation constructs, or staged versus single‑session combined approaches in adults with multi‑level cervical spondylotic myelopathy, post‑laminectomy kyphosis, or complex trauma. These studies measure fusion rates, functional neurologic recovery, reoperation, hardware-related complications, and 12–24 month patient‑reported outcomes, addressing the medium‑term durability and value of surgical choices that influence readmissions and downstream costs. Results inform surgeons and payers about which technical strategies provide the best balance of clinical effectiveness and long‑term economic value for patients assigned to this DRG.
Post‑discharge outcomes and care pathway studies focused on rehabilitation, readmission risk, and cost‑effectiveness: observational or interventional studies evaluating early mobilization protocols, outpatient physical therapy timing, care coordination interventions, and readmission prevention programs in older adults and medically complex patients after combined anterior‑posterior cervical fusion. These trials assess 30‑ and 90‑day readmission rates, functional independence, opioid use, and total episode‑of‑care costs, providing evidence on optimal discharge planning and postacute care settings. Findings are important to hospitals and payers for designing bundled payment models and targeted transitional care to reduce costly readmissions and improve recovery for patients within this DRG.

OpenPayer

Summary & Overview

Combined Anterior and Posterior Cervical Spinal Fusion without MCC: Inpatient Reimbursement Overview

DRG 430 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes